Skip to main content
. 2021 Sep 17;11(9):e049907. doi: 10.1136/bmjopen-2021-049907

Table 2.

Number of patients with PSS and their demographics per identification method

Total cohort
n (%) or mean±SD
Method A
n (%) or mean±SD
Method B
n (%) or mean±SD
Method C
n (%) or mean±SD
Method D
n (%) or mean±SD
All methods combined
n (%) or mean±SD
Patients 169 138 (100.0) 8407 (5.0) 11 893 (7.0) 5574 (3.3) 482 (0.3) 20 855 (12.3)
Female 89 432 (52.9) 6276 (74.7) 8020 (67.4) 4164 (74.7) 340 (70.5) 14 490 (69.5)
Age 51.4±16.4 48.6±15.0 57.6±18.2 49.6±14.6 42.6±12.0 53.6±17.4
Years enrolled 4.6±1.0 4.6±0.9 4.5±1.0 4.6±0.9 4.7±0.8 4.6±1.0

The table was created by the author and permission for reuse is granted to BMJ Open

Method A: patients with recorded FM, IBS and/or CFS based on ICPC-codes.

Method B: patients with at least six ICPC codes that correspond to the Robbins list in any 6-month period.

Method C: patients with reported PSS-related terminology.

Method D: patients with ≥20 points on the somatisation subscale of the 4DSQ.

CFS, chronic fatigue syndrome; 4DSQ, Four-Dimensional Symptom Questionnaire; FM, fibromyalgia; IBS, irritable bowel syndrome; ICPC, International Classification of Primary Care; PSS, persistent somatic symptoms.